sur CSL
CSL Broadmeadows Facility Wins 2025 Facility of the Year Award
CSL's Broadmeadows facility in Australia has been named the Overall Winner of the 2025 Facility of the Year Award (FOYA) by the International Society for Pharmaceutical Engineering (ISPE). This recognition highlights CSL's commitment to innovation and sustainability within the biopharmaceutical sector.
The facility enhances plasma-derived therapies production for various conditions using advanced technologies like automation, real-time monitoring, robotics, and digital twin infrastructure. These innovations have significantly increased its plasma processing capacity to over 10 million liters annually.
Sustainability is also a key feature, with reusable filters, energy-efficient systems, and an automated warehouse contributing to its eco-friendly design. This accolade also follows a previous award in the Pharma 4.0™ category for the Broadmeadows facility's use of digital technologies.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de CSL